Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Diecke, Sebastian ^a,b,c   Lu, Jiamiao ^a   Lee, Jaecheol ^a   Termglinchan, Vittavat ^a   Kooreman, Nigel G ^a   Burridge, Paul W ^a   Ebert, Antje D ^a   Churko, Jared M ^a   Sharma, Arun ^a   Kay, Mark A ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c BERLIN INSTITUTE OF HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CODON; EPSTEIN BARR VIRUS ANTIGEN; HOMEODOMAIN PROTEIN; LIN-28 PROTEIN, HUMAN; MYC PROTEIN; NANOG PROTEIN, HUMAN; PROTEIN P53; RNA BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CODON; CYTOLOGY; FIBROBLAST; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; INNATE IMMUNITY; INTRON; KARYOTYPING; METABOLISM; MONONUCLEAR CELL; MOUSE; NUCLEAR REPROGRAMMING; PLASMID; PLURIPOTENT STEM CELL;

ANIMALS; CELLS, CULTURED; CELLULAR REPROGRAMMING; CODON; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FIBROBLASTS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNITY, INNATE; INTRONS; KARYOTYPING; LEUKOCYTES, MONONUCLEAR; MICE; MICROSCOPY, FLUORESCENCE; NANOG HOMEOBOX PROTEIN; PLASMIDS; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84940786435     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08081     Document Type: Article

References (45)

1. Takahashi, K., Okita, K., Nakagawa, M., Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2, 3081-3089 (2007).
2. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
3. Bock, C. et al. Reference Maps of human ES and iPS cell variation enable highthroughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
4. Lee, J. et al. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 16, R41 (2014).
5. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
6. Jia, F. et al. A nonviral minicircle vector for deriving human iPS cells. NatMethods 7, 197-199 (2010).
7. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
8. Chou, B. K. et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21, 518-529 (2011).
9. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409-412 (2011).
10. Mandal, P. K., Rossi, D. J. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 8, 568-582 (2013).
11. Narsinh, K. H. et al. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 6, 78-88 (2011).
12. Diecke, S., Lisowski, L., Kooreman, N. G., Wu, J. C. Second generation codon optimized minicircle (CoMiC) for nonviral reprogramming of human adult fibroblasts. Methods in Mol Biol 1181, 1-13 (2014).
13. Kay, M. A., He, C. Y., Chen, Z. Y. A robust system for production of minicircle DNA vectors. Nat Biotechnol 28, 1287-1289 (2010).
14. Lu, J., Zhang, F., Kay, M. A. A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro. Mol Ther 21, 954-963 (2013).
15. Tiemann, U. et al. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Cytometry A 79, 426-435 (2011).
16. Aggen, D. H. et al. Single-chain ValphaVbeta T-cell receptors function without mispairing with endogenous TCR chains. Gene Ther 19, 365-374 (2012).
17. Lu, J., Zhang, F., Xu, S., Fire, A. Z., Kay, M. A. The extragenic spacer length between the 5' and 3' ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors. Mol Ther 20, 2111-2119 (2012).
18. Warlich, E. et al. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther 19, 782-789 (2011).
19. Papp, B., Plath, K. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res 21, 486-501 (2011).
20. Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8, 424-429 (2011).
21. Lee, J. et al. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151, 547-558 (2012).
22. Stetson, D. B., Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93-103 (2006).
23. Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat Methods 11, 855-860 (2014).
24. Chambers, S. M. et al.Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27, 275-280 (2009).
25. Gonzalez, F., Boue, S., Izpisua Belmonte, J. C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12, 231-242 (2011).
26. Mack, A. A., Kroboth, S., Rajesh, D., Wang, W. B. Generation of induced pluripotent stem cells from CD341 cells across blood drawn from multiple donors with non-integrating episomal vectors. PloS one 6, e27956 (2011).
27. Dowey, S. N., Huang, X., Chou, B. K., Ye, Z., Cheng, L. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc 7, 2013-2021 (2012).
28. Piao, Y., Hung, S. S., Lim, S. Y., Wong, R. C., Ko, M. S. Efficient generation of integration-free human induced pluripotent stem cells from keratinocytes by simple transfection of episomal vectors. Stem Cells Transl Med 3, 787-791 (2014).
29. Zhou, T. et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7, 2080-2089 (2012).
30. Hu, K. All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. Stem cells dev 23, 1285-1300 (2014).
31. de Almeida, P. E. et al. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun 5, 3903 (2014).
32. Gonzalez, F. et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci USA 106, 8918-8922 (2009).
33. Young, L. S., Rickinson, A. B. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757-768 (2004).
34. Stadtfeld, M.,Hochedlinger, K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 24, 2239-2263 (2010).
35. Kaji, K. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771-775 (2009).
36. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801 (2009).
37. Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51-63 (2010).
38. Esteban, M. A. et al. The mesenchymal-to-epithelial transition in somatic cell reprogramming. Curr Opin Genet Dev 22, 423-428 (2012).
39. Liu, X. et al. Sequential introduction of reprogramming factors reveals a timesensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol 15, 829-838 (2013).
40. Redmer, T. et al. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep 12, 720-726 (2011).
41. Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476 (2009).
42. Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A., Buller, R. M. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 270, 15974-15978 (1995).
43. Amit, M. et al.No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses. Stem Cells 23, 761-771 (2005).
44. Yoshioka, N. et al. Efficient generation of human iPSCs by a synthetic selfreplicative RNA. Cell Stem Cell 13, 246-254 (2013).
45. Hou, P. et al. Pluripotent stem cells induced from mouse somatic cells by smallmolecule compounds. Science 341, 651-654 (2013).